These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7485806)

  • 21. Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium.
    Handa VL; Bachus KE; Johnston WW; Robboy SJ; Hammond CB
    Obstet Gynecol; 1994 Aug; 84(2):215-8. PubMed ID: 8041532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of post-menopausal vaginal atrophy and atrophic vaginitis.
    Castelo-Branco C; Cancelo MJ; Villero J; Nohales F; Juliá MD
    Maturitas; 2005 Nov; 52 Suppl 1():S46-52. PubMed ID: 16139449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.
    Labrie F; Cusan L; Gomez JL; Côté I; Bérubé R; Bélanger P; Martel C; Labrie C
    Menopause; 2009; 16(1):30-6. PubMed ID: 18820592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose (0.3 mg) synthetic conjugated estrogens A is effective for managing atrophic vaginitis.
    Marx P; Schade G; Wilbourn S; Blank S; Moyer DL; Nett R
    Maturitas; 2004 Jan; 47(1):47-54. PubMed ID: 14706765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of vaginal estrogen therapy on urinary incontinence in postmenopause].
    Schär G; Köchli OR; Fritz M; Haller U
    Zentralbl Gynakol; 1995; 117(2):77-80. PubMed ID: 7709677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy of atrophic colpitis--is a reduction of estrogen dosage in local administration possible?].
    Feiks A; Grünberger W
    Gynakol Rundsch; 1991; 31 Suppl 2():268-71. PubMed ID: 1790951
    [No Abstract]   [Full Text] [Related]  

  • 27. Non-invasive analysis of hormonal variations and effect of postmenopausal Vagifem treatment on women using in vivo high wavenumber confocal Raman spectroscopy.
    Duraipandian S; Zheng W; Ng J; Low JJ; Ilancheran A; Huang Z
    Analyst; 2013 Jul; 138(14):4120-8. PubMed ID: 23730685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):923-31. PubMed ID: 19424093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Bérubé R; Bélanger P; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):897-906. PubMed ID: 19436226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect and safety of 17 beta-estradiol vaginal tablet in postmenopausal women with urogenital symptoms.
    Manonai J; Theppisai U; Chittacharoen A
    J Med Assoc Thai; 2001 Jul; 84(7):1015-20. PubMed ID: 11759960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of micronized estradiol vaginal cream.
    Gordon WE; Hermann HW; Hunter DC
    South Med J; 1979 Oct; 72(10):1252-3, 1258. PubMed ID: 482979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of raloxifene on sexual function in postmenopausal women.
    Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A
    Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of vaginal use of topical estriol in postmenopausal women with urogenital atrophy.
    Chuery AC; Speck NM; de Moura KF; Belfort PN; Sakano C; Ribalta JC
    Clin Exp Obstet Gynecol; 2011; 38(2):143-5. PubMed ID: 21793275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women.
    Hedrick RE; Ackerman RT; Koltun WD; Halvorsen MB; Lambrecht LJ
    Menopause; 2009; 16(1):132-40. PubMed ID: 18971794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrophic vaginitis. Estrogen can help.
    Mayo Clin Health Lett; 2001 Jan; 19(1):6. PubMed ID: 11201532
    [No Abstract]   [Full Text] [Related]  

  • 36. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):907-22. PubMed ID: 19436225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyaluronic acid in the treatment of postmenopausal women with atrophic vaginitis.
    Karaosmanoglu O; Cogendez E; Sozen H; Asoglu MR; Akdemir Y; Eren S
    Int J Gynaecol Obstet; 2011 May; 113(2):156-7. PubMed ID: 21420087
    [No Abstract]   [Full Text] [Related]  

  • 38. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial.
    Simon JA; Bouchard C; Waldbaum A; Utian W; Zborowski J; Snabes MC
    Obstet Gynecol; 2007 Mar; 109(3):588-96. PubMed ID: 17329509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postmenopausal vaginal atrophy correlates with decreased estradiol and body mass index and does not depend on the time since menopause.
    Repse-Fokter A; Takac I; Fokter SK
    Gynecol Endocrinol; 2008 Jul; 24(7):399-404. PubMed ID: 18645712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogens and the urogenital tract. Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring.
    Smith P
    Acta Obstet Gynecol Scand Suppl; 1993; 157():1-26. PubMed ID: 8393609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.